As of 2025-06-13, the Fair Value of bluebird bio Inc (BLUE) is -259.79 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 4.97 USD, the upside of bluebird bio Inc is -5,327.24%.
With the market price of 4.97 USD and our fair value calculation, bluebird bio Inc (BLUE) is not a good investment. Investing in BLUE stocks now will result in a potential loss of 5,327.24%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -618.70 | -819.38 | -266.58 | -211.91 | -240.71 | -431.46 |
| YoY growth | 21.64% | -32.44% | 67.47% | 20.51% | -13.59% | 12.72% |
| Market Cap (mil) | 48.66 |
| P/E | |
| Forward P/E |
| EPS | -20.43 |
| Avg earnings growth rate | 12.72% |
| TTM earnings | -199.98 |